Skip to main content

Table 1 Patients' clinical characteristics (aged ≥ 75 years)

From: Monitoring of serum magnesium levels during long-term use of proton pump inhibitors in elderly japanese patients: is it really necessary or not?

 

PPI (+)

PPI (-)

P value

Gender male/female, (%)

16/31 (34.0/66.0)

35/50 (41.2/58.8)

0.460

Age mean, years

83.7 ± 5.5

81.4 ± 5.2

0.013

Laboratory measurements

 Magnesium (mg/dL)

2.1 ± 0.2

2.2 ± 0.3

0.005

 Sodium (mEq/dL)

141.2 ± 2.9

140.9 ± 2.4

0.275

 Potassium (mEq/dL)

4.1 ± 0.4

4.3 ± 0.5

0.011

 Blood urea nitrogen (mg/dL)

17.6 ± 5.0

20.3 ± 9.3

0.176

 eGFR (mL/min)

62.5 ± 17.1

59.2 ± 19.0

0.484

 Creatinine (mg/dL)

0.8 ± 0.3

0.9 ± 0.5

0.442

 Albumin (g/dL)

4.1 ± 0.3

4.1 ± 0.4

0.549

Disorder present/absent, (%)

 Diabetes mellitus

11/36 (23.4/76.6)

49/36 (57.6/42.4)

<0.001

 Hypertension

36/11 (76.6/23.4)

58/27 (68.2/31.8)

0.422

 Hyperlipidemia

29/18 (61.7/38.3)

35/50 (41.2/58.8)

0.030

 Liver disease

2/45 (4.3/95.7)

2/83 (2.4/97.6)

0.616

 Renal disease

3/44 (6.4/93.6)

10/75 (11.8/88.2)

0.378

 Allergic disease

3/44 (6.4/93.6)

5/80 (5.9/94.1)

1.000

 Respiratory disease

0/47 (0.0/100.0)

3/82 (3.5/96.5)

0.552

  1. Abbreviation: eGFR Estimated glomerular filtration rate